BeyondSpring Inc (BYSI)

[saigai]

adding too easy

[BoilerRoom]

Your always welcome…

[cjstocksup]

Thanks. I think we will see $50.00 soon. They have a conference in Aug. coming up. Very low float and IMO it will be getting much lower as the institutions load more shares due to the success of the Phase 3 trials just released last week.

Wow nice call!!! Wow just wow!!!

BYSI

[Montanore]

This is a buy and hold. Target: $100

[BoilerRoom]

$BYSI I’m out guys I’m too nervous to hold stocks over weekends. Nothing against company just all stocks in general. Will jump back in next Monday or Tuesday. Have a great weekend all.

[BoilerRoom]

$BYSI adding the dip

[BoilerRoom]

Thanks for finding this CJ! I’m a little late but very thankful….

[BoilerRoom]

In $28.40!

[BoilerRoom]

Wow nice call!!! Wow just wow!!!

[saigai]

and now...wow..what a stroke of luck to find this..thanks to the poster on smart money. i love that board

[crudeoil24]

25.92

[PStockPickz]

Looking good for another big squeeze

[make it happen]

Think it's possible to hit teens from gap up of 9's? Hell of a gap from 9's

[crudeoil24]

Huang stated BYSI has $91 million on its balance sheet, which will take the company into July of 2022.

[crudeoil24]

EXCLUSIVE: BeyondSpring CEO Talks Better-Than-Expected Trial Results That Sent The Stock Soaring
4:26 pm ET August 5, 2021 (Benzinga) Print
BeyondSpring Inc (NASDAQ: BYSI) recently announced positive topline data from its DUBLIN-3 registrational trial in plinabulin in combination with docetaxel for the treatment of second and third line non-small cell lung cancer.

The study showed survival benefits and side effect reduction, BeyondSpring CEO Lan Huang said Thursday on Benzinga's Stock Market Livestream.

BeyondSpring is focused on developing transformative cancer medicines for patients, Huang said.

BeyondSpring has plans to discuss the company's positive trial data with the FDA later this year, she said.

There are 1.9 million patients who develop lung cancer globally each year, Huang said, adding the market for BeyondSpring is "huge."

The stock surged nearly 150% higher following the announcement this week. The BeyondSpring CEO told Benzinga the company doesn't have any plans to initiate a share offering at this time.

Huang told Benzinga BeyondSpring has $91 million on its balance sheet, which will take the company into July of 2022.

She attributes the dramatic move in the stock price to the better-than-expected trial results.

Along with the ongoing plinabulin trials, the company has three other preclinical drug trials in the pipeline, Huang said.

BeyondSpring is always thinking about potential partnerships that could help accelerate the development of the company's transformative cancer medicines, the CEO said.

BeyondSpring's current FDA submission received FDA priority review with a PDUFA date of Nov. 30.

The November deadline "is definitely a very important day," Huang told Benzinga.

BYSI Price Action: BeyondSpring shares pulled back 18.36% in Thursday's session, closing at $21.70.

See the full interview here:

BYSI Price Action: BeyondSpring has traded as high as $30 and as low as $8.90over a 52-week period.

At last check Thursday, the stock was down 15.90% at $22.29.

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

[saigai]

too much information

[crudeoil24]

I have a large coffee cup. lol. We are holding a potential huge upside runner.

BYSI

[saigai]

thar she blows

[saigai]

good to see you here. as yu are the cup half empty voice of reason and get me riled up sometimes ..so if you are a bull here.. thats a good sign!!!

[crudeoil24]

Wainwright has a $100.00 price target.

[crudeoil24]

Solid pipeline, plus any morning BYSI could surge 40.00+

[cjstocksup]

HOLD!

[saigai]

in yesterday at 22.53 and adding through the pre mkt..feel like this is a big timer

[crudeoil24]

Bought starter position yesterday. In @ 21.70 > BYSI

[crudeoil24]

Also, this low trading float is 20M shares. 7% short interest as of July 15. > Yearly Revenue generated by each employee is less than $2000.
An upcoming announcement on worldwide potential revenue will give clarification.
So, folks here are investing and forward looking. BYSI

[cjstocksup]

Shorts will be in big trouble ahead they lied for 2 days about an offering coming that is the only reason we did not close over $40.00 yesterday. Today in he CEO interview on Behzinga she confirmed over 91 million in cash enough through next June. No offering. Now we have to set up for the next big run in the days ahead they had shorted us so low.
BYSI

[Actualfactual]

That’s very good insight and a main reason why I’m waiting to go long

[crudeoil24]

Thanks CJ > good information! BYSI

[cjstocksup]

No chance IMO they just went over this at the last BYSI CC no offerings needed.
Shorts are trapped.
Transcript from the last earnings call:

"Our cash balance at the end of Q1 was $90.6 million, which we believe will be sufficient to support our ongoing clinical programs over the next year including our immune-oncology pipeline and to prepare for the potential launch of plinabulin in CIN in early 2022."

[crudeoil24]

Possible upcoming shelf placement when HC Wainwright & Co. Upgrades BeyondSpring to Buy; Announces $100 Price Target.
I have often seen Wainwright be the placement runner shortly after announcing a huge PT.

[makinezmoney]

$BYSI: Plinabulin presentation from June 2021



https://beyondspringpharma.com/wp-content/uploads/2021/06/BYSI-RD-Day-Event-Slides-Final-1.pdf


GO $BYSI

[NewbieDoobyDoo]

From Business Insider:

https://www.msn.com/en-us/health/medical/a-small-biopharma-stock-soars-198percent-after-the-company-says-it-will-seek-fda-approval-following-a-successful-cancer-drug-trial/ar-AAMWqcY

A small biopharma stock soars 198% after the company says it will seek FDA approval following a successful cancer-drug trial

[e-mail] (Isabelle Lee) 1 hr ago

[PStockPickz]

Will see tomorrow if the gains hold

[NewbieDoobyDoo]

Not much traffic on this particular board. Maybe that will change.

I can't tell if BYSI has real momentum upward, or if we're just seeing a pump.

[makinezmoney]

$BYSI: Monster news....... Monster UPGRADE to $100 by Wainwright

No wonder its on a roll right now



Big boost to $40 already today.


This could be the next $SAVA big time mover



GO $BYSI